Evaluation of disease and medication knowledge levels of diabetic patients

dc.authorid0000-0001-8902-7274
dc.authorid0000-0001-8560-8450
dc.authorid0000-0003-1069-7975
dc.contributor.authorUmar, Rashida Muhammad
dc.contributor.authorÇattık, Büşra Nur
dc.contributor.authorAslan, Selim
dc.date.accessioned2023-10-03T07:38:35Z
dc.date.available2023-10-03T07:38:35Z
dc.date.issued2023
dc.departmentİstanbul Medipol Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü, Klinik Eczacılık Ana Bilim Dalı
dc.description.abstractBackground and Aims: Diabetes mellitus is a public health problem with a significant economic burden to society. Patient attitude is a significant determinant of adherence and clinical outcomes. We aimed to evaluate the disease and medication knowledge level of diabetic patients and possible patient-related predictive factors. Methods: Adult diabetic patients were included in the study. Patients' demographic and health-related data were collected using a pre-prepared form. Two questionnaires, KAP knowledge tool and Medication Assessment tool were used to assess the disease and medication knowledge levels of patients. Results: The mean age of 159 patients was 54.44 & PLUSMN;12.24 years. The disease and medication knowledge scores were high with an average of 13.9 & PLUSMN;1.74 and 5.26 & PLUSMN;0.53, respectively. Higher scores were linked to being male (p=0.042; p=0.007) and higher educational status (p<0.001; p=0.006). Lower scores were recorded in patients with comorbidities (p=0.002; p<0.001), older patients (p<0.001), longer disease duration (p<0.001; p=0.009), longer antidiabetic drug use (p<0.001; p=0.009) and using more drugs (p=0.002; p=0.006). None of the patients could mention any possible side effects of their medications. Conclusion: It can be deduced that patient-related factors are significant predictors of patients' disease and medication knowledge. Patient-specific education in addition to rational pharmacological intervention is necessary to achieve better clinical outcomes.
dc.identifier.citationUmar, R. M., Çattık, B. N. ve Aslan, S. (2023). Evaluation of disease and medication knowledge levels of diabetic patients. İstanbul Journal of Pharmacy, 53(2), 103-109. https://doi.org/10.26650/IstanbulJPharm.2023.1180952
dc.identifier.doi10.26650/IstanbulJPharm.2023.1180952
dc.identifier.endpage109
dc.identifier.issn2587-2087
dc.identifier.issue2
dc.identifier.startpage103
dc.identifier.urihttps://doi.org/10.26650/IstanbulJPharm.2023.1180952
dc.identifier.urihttps://hdl.handle.net/20.500.12511/11518
dc.identifier.volume53
dc.identifier.wos001061703800001en_US
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.institutionauthorUmar, Rashida Muhammad
dc.institutionauthorÇattık, Büşra Nur
dc.institutionauthorAslan, Selim
dc.language.isoen
dc.publisherIstanbul University
dc.relation.ispartofİstanbul Journal of Pharmacyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectDiabetes Mellitus
dc.subjectDisease Knowledge
dc.subjectMedication Knowledge
dc.subjectPatient Factors
dc.titleEvaluation of disease and medication knowledge levels of diabetic patients
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Umar-Rashida-2023.pdf
Boyut:
116.26 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: